| | Identification | Back Directory |  | [Name] 
 1,5-Dihydropyrrolo[3,2-a]pyrimidine-2,4-dion
 |  | [CAS] 
 65996-50-1
 |  | [Synonyms] 
 65996-50-1
 1,5-dihydro-pyrrolo[3,2-a]pyri
 5H-Pyrrolo[3,2-d]pyriMidine-2,4-diol
 1-Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione
 1,5-DIHYDROPYRROLO[3,2-A]PYRIMIDINE-2,4-DION
 1,5-DIHYDRO-PYRROLO[3,2-A]PYRIMIDINE-2,4-DIONE
 1,5-DIHYDRO-PYRROLO[3,2-D]PYRIMIDINE-2,4-DIONE
 1H,2H,3H,4H,5H-pyrrolo[3,2-d]pyriMidine-2,4-dione
 1,5-Dihydro-2H-pyrrolo[3,2-d]pyrimidine-2,4(3H)-dione
 |  | [Molecular Formula] 
 C6H5N3O2
 |  | [MDL Number] 
 MFCD08059275
 |  | [MOL File] 
 65996-50-1.mol
 |  | [Molecular Weight] 
 151.12
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 >360 °C(Solv: water (7732-18-5))
 |  | [density ] 
 1.516±0.06 g/cm3(Predicted)
 |  | [storage temp. ] 
 2-8°C
 |  | [form ] 
 powder to crystal
 |  | [pka] 
 11.32±0.20(Predicted)
 |  | [color ] 
 White to Light yellow to Light orange
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 1,5-Dihydropyrrolo[3,2-a]pyrimidine-2,4-dion is used for the preparation of pyrazolopyrimidine derivatives or analogs thereof as CCR4 function modulators.
 |  | [Synthesis] 
 
 General procedure for the synthesis of 1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione from (E)-6-(2-(dimethylamino)vinyl)-5-nitropyrimidine-2,4(1H,3H)-dione: (E)-6-(2-(dimethylamino)vinyl)-5-nitropyrimidine-2,4(1H,3H)-dione (1 g, 4.4 mmol) was dissolved in freshly prepared glacial acetic acid (50 mL) and stirred to form a slurry. Under stirring, zinc powder (stabilized, 1g per batch, 2g total) was added in two batches with an interval of 1 hour. The reaction mixture was stirred overnight and the color of the slurry was observed to change gradually from yellow to light yellow to off-white. After completion of the reaction, the mixture was filtered and the filtrate was concentrated under vacuum to obtain a brown slurry. The product was separated from the brown slurry by ethanol precipitation to give a white solid (0.6 g, 89.8% yield). The spectral data of the product were consistent with those reported in the literature.1H NMR (400 MHz, DMSO-d6): δ 5.82-5.83 (t, 1H, J=2.28 Hz), 7.12-7.13 (t, 1H, J=2.72 Hz, J=2.96 Hz), 10.57 (s, 1H), 10.74 (s, 1H), 11.82 (s. 1H).13C NMR (400 MHz, DMSO-d6): δ 96.5, 110.9, 127.4, 135.1, 152.0, 156.3. |  | [References] 
 [1] Bioorganic and Medicinal Chemistry,  2015,  vol. 23,  # 15,  p. 4354 - 4363
 [2] Patent: US2016/257696,  2016,  A1. Location in patent: Paragraph 0068
 [3] Patent: WO2009/62258,  2009,  A1. Location in patent: Page/Page column 98
 [4] ChemMedChem,  2018,  vol. 13,  # 2,  p. 178 - 185
 | 
 |  |